What you are looking for?

Aesthetic use of botulinum toxin

This section describes the use of botulinum toxin in aesthetic treatments. The section does not contain any, and should not be used as, treatment recommendation. Please contact your healthcare practitioner for further inquiries.
WHY TOXNIS?
TREATMENT AREAS
YOUR TREATMENT
HOW IT WORKS

Why toxins?

Our expressions are part of who we are, but as we age our faces don’t always communicate what we want them to.1 Over time, changes to the underlying structure of the skin result in folds and wrinkles that alter the appearance of the face.2 The appearance of glabellar lines (the vertical frown lines between the eyebrows) and crow’s feet can cause our faces to look old, sad, tired or angry, regardless of how we feel.3 A disconnect between what our faces express and how we feel can reduce our self-confidence and affect our quality of life.4

TREATMENT AREAS

Botulinum toxin is used to reduce the appearance of moderate to severe glabellar lines (frown lines) and crow’s feet. Approved indications vary between countries. A qualified healthcare practitioner in your area can provide you with more information on approved aesthetic indications for botulinum toxin.

Your treatment

Restylane® SKINBOOSTERS™ gradually builds up your skin’s hydration and smoothness. A typical treatment program starts with 3 treatment sessions, 2-4 weeks apart. You will notice an improvement already after the first session, but the full effect will be visible after the last session. After these initial treatments, a maintenance treatment is typically recommended every 4-6 months to ensure lasting results.

 

How it works

Botulinum toxin is produced by the bacterium Clostridium botulinum. There are different types of botulinum toxins, type A-H, where type A and B are used in medical and aesthetic treatments. 

Botulinum toxin is one of the most poisonous biological substances known. More precisely, it is a neurotoxin, which reversibly blocks the release of a neurotransmitter called acetylcholine from the nerve endings. This prevents the muscles from contracting, and thereby helps to remove wrinkles formed by repeated facial expressions (frown lines and crow’s feet). 

Each brand uses its own potency unit to describe the amount of toxin in their respective vials. The injection doses used in aesthetics are comparably low to only produce a local effect in the muscle that is being treated. Only a qualified healthcare practitioner should administer botulinum toxin for aesthetic or other treatments. 

Healthcare practitioners will inform patients of risks and side effects before treatment, as well as of possible contraindications. Please see also the Patient Safety Information. NB! The information here does not in any way replace professional information from the treating healthcare practitioner.

Before & After

See how botulinum toxin can help.

Skin insights

Reduce expression lines without getting a frozen look

Reduce expression lines such as crow’s feet and glabellar lines with injectables while still being able to express yourself.

Getting rid of crow’s feet and glabellar lines for men

Many men are worried that aesthetic treatments for crow’s feet and glabellar lines will make them look stiff.

The top 5 questions to ask before an aesthetic treatment

Want to look younger, look fresh or change your facial proportions or facial features?

OUR PORTFOLIO OF PRODUCTS

Galderma has developed a diverse portfolio of products that work holistically together.

REFINE

Refine your facial features by lifting and shaping contours, filling lines and wrinkles or creating natural volume.

REFRESH

Refresh your skin from within with a boost of deep hydration, for a refreshed and vibrant look that lasts.

RENEW

Renew the structure of your skin with a collagen activator that gradually builds the foundation of the youthful, firmer you.

REFERENCES

1 Finn CJ et al. Dermatol Surg 2003;29(5):450–455
2 Finn CJ et al. Dermatol Surg 2003;29(5):450–455
3 Finn CJ et al. Dermatol Surg 2003;29(5):450–455.; Carruthers A et al. J Cosmet Laser Ther 2007;9 (Suppl 1):6–10.
4 Finn CJ et al. Dermatol Surg 2003;29(5):450–455.; Carruthers A et al. J Cosmet Laser Ther 2007;9 (Suppl 1):6–10.